Precigen to Announce First Quarter 2026 Financial Results and Provide Business Updates on May 13
Today, in Germantown, Maryland, Precigen, Inc. (Nasdaq: PGEN), a company focused on developing cutting-edge precision medicines to enhance patient well-being, revealed its plans to unveil the results of its first quarter in 2026.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments